AGM
SGMO

Alpine Global Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Alpine Global Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,588
Closed -$83K – 377
2022
Q4 		$83K Buy
+26,588
New +$103K 0.03% 351
2020
Q1 		– Sell
-31,831
Closed -$266K – 411
2019
Q4 		$266K Buy
+31,831
New +$293K 0.06% 289

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpine Global Management's SGMO Position: Q1 2023 in Review

Alpine Global Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2023, closing a stake of 26,588 shares — an estimated $83K sold.

Alpine Global Management first reported a position in SGMO in Q4 2019 and held it in 2 quarters. The position peaked at $266K in Q4 2019. 179 funds tracked by Wall St. Rank hold SGMO as of Q1 2023.

  • Alpine Global Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 26,588 SANGAMO THERAPEUTICS INC shares in Q1 2023, an estimated $83K.
  • Alpine Global Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2019 and held it in 2 quarters.
  • Alpine Global Management's SANGAMO THERAPEUTICS INC position peaked at $266K in Q4 2019.
  • 179 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.